{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:56:55Z","timestamp":1771531015042,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T00:00:00Z","timestamp":1192060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Asthma is a heterogeneous disease that has been increasing in incidence throughout western societies and cytokines, including proinflammatory tumour necrosis factor alpha (TNF-\u03b1), have been implicated in the pathogenesis of asthma. Anti-TNF-\u03b1 therapies have been established successfully in the clinic for diseases such as rheumatoid arthritis and Crohn's disease. TNF-\u03b1-blocking strategies are now being trialled in asthma; however, their mode of action is poorly understood. Based on the observation that TNF-\u03b1 induces lymph node hypertrophy we have attempted to investigate this as a mechanism of action of TNF-\u03b1 in airway inflammation by employing two models of murine airway inflammation, that we have termed short and long models, representing severe and mild\/moderate asthma, respectively. The models differ by their immunization schedules. In the short model, characterized by eosinophilic and neutrophilic airway inflammation the effect of TNF-\u03b1 blockade was a reduction in draining lymph node (DLN) hypertrophy, eosinophilia, interleukin (IL)-5 production and immunoglobulin E (IgE) production. In the long model, characterized by eosinophilic inflammation, TNF-\u03b1 blockade produced a reduction in DLN hypertrophy and IL-5 production but had limited effects on eosinophilia and IgE production. These results indicate that anti-TNF-\u03b1 can suppress DLN hypertrophy and decrease airway inflammation. Further investigations showed that anti-TNF-\u03b1-induced inhibition of DLN hypertrophy cannot be explained by preventing l-selectin-dependent capture of lymphocytes into the DLN. Given that overall TNF blockade was able to suppress the short model (severe) more effectively than the long model (mild\/moderate), the results suggest that TNF-\u03b1 blocking therapies may be more effective in the treatment of severe asthma.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2007.03509.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T22:01:56Z","timestamp":1280181716000},"page":"114-122","source":"Crossref","is-referenced-by-count":43,"title":["Tumour necrosis factor-\u03b1 blockade suppresses murine allergic airways inflammation"],"prefix":"10.1093","volume":"151","author":[{"given":"S","family":"Hutchison","sequence":"first","affiliation":[{"name":"Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B S W","family":"Choo-Kang","sequence":"additional","affiliation":[{"name":"Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R V","family":"Bundick","sequence":"additional","affiliation":[{"name":"Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Leishman","sequence":"additional","affiliation":[{"name":"Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Brewer","sequence":"additional","affiliation":[{"name":"Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I B","family":"McInnes","sequence":"additional","affiliation":[{"name":"Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Garside","sequence":"additional","affiliation":[{"name":"Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,10,11]]},"reference":[{"key":"2022010406280846500_b1","first-page":"1","article-title":"Summary health statistics for the U.S. population: National Health Interview Survey, 2003","volume":"224","author":"Schiller","year":"2005","journal-title":"Vital Health Stat 10"},{"key":"2022010406280846500_b2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-6749(93)90029-F","article-title":"Pathology of asthma","volume":"92","author":"Hogg","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"2022010406280846500_b3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0163-7258(02)00220-6","article-title":"Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease","volume":"94","author":"Foster","year":"2002","journal-title":"Pharmacol Ther"},{"key":"2022010406280846500_b4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11882-006-0045-0","article-title":"T-cell subsets in the pathogenesis of human asthma","volume":"6","author":"Meiler","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"key":"2022010406280846500_b5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1084\/jem.174.1.103","article-title":"Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)\/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses","volume":"174","author":"Gordon","year":"1991","journal-title":"J Exp Med"},{"key":"2022010406280846500_b6","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1172\/JCI116506","article-title":"Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha","volume":"91","author":"Costa","year":"1993","journal-title":"J Clin Invest"},{"key":"2022010406280846500_b7","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"2022010406280846500_b8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1165\/ajrcmb.10.5.8179909","article-title":"Interleukin-4-, 5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines","volume":"10","author":"Bradding","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022010406280846500_b9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1440-1711.2001.00980.x","article-title":"Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma","volume":"79","author":"Thomas","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"2022010406280846500_b10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/gut.44.5.643","article-title":"Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue","volume":"44","author":"Bischoff","year":"1999","journal-title":"Gut"},{"key":"2022010406280846500_b11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2249.1993.tb05985.x","article-title":"Modulation of adhesion molecule expression on endothelial cells during the late asthmatic reaction: role of macrophage-derived tumour necrosis factor-alpha","volume":"94","author":"Lassalle","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"2022010406280846500_b12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0091-6749(99)70079-5","article-title":"Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha","volume":"104","author":"Schwingshackl","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"2022010406280846500_b13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/rccm.200601-072OC","article-title":"The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma","volume":"174","author":"Erin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2022010406280846500_b14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/thx.2005.045260","article-title":"Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma","volume":"60","author":"Howarth","year":"2005","journal-title":"Thorax"},{"key":"2022010406280846500_b15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.rmed.2005.02.031","article-title":"Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation","volume":"99","author":"Rouhani","year":"2005","journal-title":"Respir Med"},{"key":"2022010406280846500_b16","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1172\/JCI28295","article-title":"Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function","volume":"116","author":"Idzko","year":"2006","journal-title":"J Clin Invest"},{"key":"2022010406280846500_b17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ni1005","article-title":"Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection","volume":"4","author":"McLachlan","year":"2003","journal-title":"Nat Immunol"},{"key":"2022010406280846500_b18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.it.2005.07.007","article-title":"TNF-blocking therapies: an alternative mode of action?","volume":"26","author":"Choo-Kang","year":"2005","journal-title":"Trends Immunol"},{"key":"2022010406280846500_b19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1126\/science.2125367","article-title":"Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo","volume":"250","author":"Murphy","year":"1990","journal-title":"Science"},{"key":"2022010406280846500_b20","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"2022010406280846500_b21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cellbi.2005.07.002","article-title":"FITC-induced murine pulmonary inflammation: CC10 up-regulation and concurrent Shh expression","volume":"29","author":"Fisher","year":"2005","journal-title":"Cell Biol Int"},{"key":"2022010406280846500_b22","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.168.9.4318","article-title":"Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help","volume":"168","author":"Smith","year":"2002","journal-title":"J Immunol"},{"key":"2022010406280846500_b23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2022010406280846500_b24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","article-title":"Neutrophilic inflammation in severe persistent asthma","volume":"160","author":"Jatakanon","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2022010406280846500_b25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/ajrccm.161.4.9812061","article-title":"Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance","volume":"161","author":"Ordonez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2022010406280846500_b26","first-page":"77","article-title":"Evidence of a role of tumour necrosis factor in refractory asthma","volume":"381","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"2022010406280846500_b27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"2022010406280846500_b28","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1053\/gast.2001.24042","article-title":"An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial","volume":"120","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"2022010406280846500_b29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000076441","article-title":"Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases","volume":"133","author":"Zuany-Amorim","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"2022010406280846500_b30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaci.2005.05.034","article-title":"TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation","volume":"116","author":"Choi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2022010406280846500_b31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1165\/ajrcmb.24.3.4071","article-title":"Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55\/p75\u2003\u2212\u2003and TNF receptor p55-deficient mice","volume":"24","author":"Broide","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022010406280846500_b32","doi-asserted-by":"crossref","first-page":"L1047","DOI":"10.1152\/ajplung.2000.279.6.L1047","article-title":"Modulation of allergic inflammation in mice deficient in TNF receptors","volume":"279","author":"Rudmann","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022010406280846500_b33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(97)12261-9","article-title":"Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma","volume":"352","author":"Kon","year":"1998","journal-title":"Lancet"},{"key":"2022010406280846500_b34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/thx.2005.045260","article-title":"Tumour necrosis factor (TNF alpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma","volume":"60","author":"Howarth","year":"2005","journal-title":"Thorax"},{"key":"2022010406280846500_b35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2005.02139.x","article-title":"Mechanisms of T cell migration to the lung","volume":"35","author":"Wardlaw","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"2022010406280846500_b36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1152\/jappl.1995.79.2.493","article-title":"Sites of leukocyte sequestration in the pulmonary microcirculation","volume":"79","author":"Gebb","year":"1995","journal-title":"J Appl Physiol"},{"key":"2022010406280846500_b37","first-page":"809","article-title":"Leukocyte kinetics in the pulmonary microcirculation: observations using real-time confocal luminescence microscopy coupled with high-speed video analysis","volume":"76","author":"Yamaguchi","year":"1997","journal-title":"Lab Invest"},{"key":"2022010406280846500_b38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/ajrccm.157.2.9704102","article-title":"Differential contribution of various adhesion molecules to leukocyte kinetics in pulmonary microvessels of hyperoxia-exposed rat lungs","volume":"157","author":"Nishio","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2022010406280846500_b39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1067\/mai.2001.114050","article-title":"L-selectin and intercellular adhesion molecule 1 mediate lymphocyte migration to the inflamed airway\/lung during an allergic inflammatory response in an animal model of asthma","volume":"107","author":"Keramidaris","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"2022010406280846500_b40","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.4049\/jimmunol.158.11.5191","article-title":"L-selectin is involved in lymphocyte migration to sites of inflammation in the skin: delayed rejection of allografts in L-selectin-deficient mice","volume":"158","author":"Tang","year":"1997","journal-title":"J Immunol"},{"key":"2022010406280846500_b41","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.4049\/jimmunol.161.12.6638","article-title":"Efficient lymphocyte migration across high endothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and beta7 integrin","volume":"161","author":"Steeber","year":"1998","journal-title":"J Immunol"},{"key":"2022010406280846500_b42","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.147.8.2565","article-title":"Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion","volume":"147","author":"Spertini","year":"1991","journal-title":"J Immunol"},{"key":"2022010406280846500_b43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2001.114703","article-title":"L-Selectin is required for the development of airway hyperresponsiveness but not airway inflammation in a murine model of asthma","volume":"107","author":"Fiscus","year":"2001","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2007.03509.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2007.03509.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/151\/1\/114\/42038733\/j.1365-2249.2007.03509.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/151\/1\/114\/42038733\/j.1365-2249.2007.03509.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T18:50:40Z","timestamp":1711651840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/151\/1\/114\/6457627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,10,11]]},"published-print":{"date-parts":[[2007,12,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03509.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,1]]},"published":{"date-parts":[[2007,10,11]]}}}